Litigation Details for Novartis Pharmaceuticals v. Accord Healthcare, Inc. (Fed. Cir. 2020)
✉ Email this page to a colleague
Novartis Pharmaceuticals v. Accord Healthcare, Inc. (Fed. Cir. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-10-20 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | 2022-06-21 |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Parties | ADAM MOSSOFF, INTELLECTUAL PROPERTY LAW PROFESSOR | ||
Patents | 8,324,283; 9,187,405 | ||
Attorneys | Robert Trenchard | ||
Firms | Goodwin Procter LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals v. Accord Healthcare, Inc.
Details for Novartis Pharmaceuticals v. Accord Healthcare, Inc. (Fed. Cir. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-03-09 | 22 | LANGUAGE OF CLAIMS – U.S. PATENT NO. 9,187,405 1. A method for reducing or preventing … INTRODUCTION U.S. Pat. No. 9,187,405 claims methods for treating relapsing-remitting… 3. The ’405 Patent Novartis filed a patent application in Great Britain on … makes here. The Patent Office rejected all challenges and upheld the Patent. (Appx209 (IPR Final…405 patent to have an adequate written description.” (Appx18861.) In other words, “as the Patent Office | External link to document | |
2022-08-04 | 73 | ................................10 U.S. Patent No. 8,324,283.........................................…autoimmune disorders other than RRMS. U.S. Patent No. 8,324,283 at col. 12, ll. 19–37. To meet the new …outcome of this case or the patent at issue, U.S. Patent No. 9,187,405 (“’405 patent”). They submit this brief… in patent law. In so doing, the decision jeopardizes the validity of thousands of issued patent claims…percentage of drug patents. Likewise, pharmaceutical and biotechnology patent applicants often must | External link to document | |
2022-08-17 | 77 | matters). ’405 patent U.S. Patent No. 9,187,405 ANDA Abbreviated…(xx:yy-zz) If this format cites to a patent it refers to column xx, (xxxxx:yy-zz) lines…yy-zz. cl.xx Claim no.xx [in cited patent] Appx Joint Appendix (cited by… brought against the ‘405 patent in the PTAB by other generics (not HEC). …rejection for the ‘405 patent application. Appx3652-3678. Novartis | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |